Description
The Defense Logistics Agency – Troop Support is issuing a Sources‑Sought (RFI) to identify manufacturers or authorized dealers capable of supplying the FDA‑approved 2 mg Atropine autoinjector for military use. The information will be used to shape a future firm‑fixed‑price IDIQ contract (1‑year base period with up to four one‑year extensions) that could total up to five years. Respondents must confirm FDA licensing, detail production capacity, packaging, lead‑times, and pricing. Minimum guaranteed quantity is 90,000 units per year, with a potential maximum of 360,000 units annually. Delivery will be FOB destination to DLA Distribution Susquehanna in New Cumberland, PA.
• Required product: FDA‑approved 2 mg Atropine sulfate autoinjector (pressure‑activated, 0.7 mL).
• Minimum annual quantity: 90,000 units; maximum annual quantity: 360,000 units (up to 1.8 M over the contract’s life).
• Must meet detailed packaging (MIL‑STD‑2073‑1), labeling, and shelf‑life (≥ 24 months remaining on delivery) requirements as outlined in MPID No. 2.
• Respondents must provide manufacturing or dealer status, FDA registration, CAGE code, NAICS 325412, capacity, lead‑times, and price estimates for up to five years.